Jeff Galvin, CEO of American Gene Technologies, shares his journey from Silicon Valley to biotech and the future of gene therapy. Watch the interview on Bio Blast! https://lnkd.in/gVYYv7FX #genetherapy #biotech #innovation
Addimmune™
Biotechnology Research
Rockville, Maryland 636 followers
Imagine a World Without HIV℠
About us
At Addimmune, our mission is to deliver the world’s first functional cure for HIV. Using viral vector delivery, we are seeking to give the immune system the tools it needs to resist and ultimately clear the virus.
- Website
-
https://www.addimmune.com/
External link for Addimmune™
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Rockville, Maryland
- Type
- Privately Held
- Founded
- 2023
- Specialties
- Gene Therapy, HIV, Clinical Research, and Biotechnology
Locations
-
Primary
Rockville, Maryland, US
Employees at Addimmune™
Updates
-
Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. https://loom.ly/96TZ0jU #HIV #celltherapy #biotech
-
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on their research for HIV! https://loom.ly/jAThqIU #HIVResearch #ClinicalTrials
-
Can genetic evidence make drugs more effective? A new study in Nature suggests YES. Drug mechanisms with genetic support have a 2.6x higher chance of success. This could change the future of drug development! https://loom.ly/NxSxjXk #genetics #science #healthcare
-
Dr. Marcus Conant will be participating in a roundtable on cell and #GeneTherapy alongside Andrew Dietz, MD, of @ShapeTX at this year’s CMO Summit 360 on April 18 at 12:50 PM ET. Learn more: https://loom.ly/EjJavXE #CMO360
-
Dr. Marcus Conant will be participating in a roundtable on cell and #GeneTherapy alongside Andrew Dietz, MD, of Shape Therapeutics Inc. at this year’s CMO Summit 360 on April 18 at 12:50 PM ET. Learn more: https://brnw.ch/21wIUgG #CMO360
Chief Medical Officer Summit 360º
cmo360.org
-
Exciting news for the future of medicine! The strategic market insight company Nova 1 values the cell & gene therapy market @ $18 billion in 2023 growing at a CAGR of 18% over the next decade. They see a near $100 billion market size by 2033. https://loom.ly/kpuPhu4 #genetherapy #futureofmedicine
-
This #NYHAAD, we support NYHAAD and their mission to create meaningful and intentional spaces for young people to ask questions, learn, and talk about the impacts of HIV and their community. #StopHIVTogether #EndHIVStigma
-
This #NYHAAD, we support @NYHAAD and their mission to create meaningful and intentional spaces for young people to ask questions, learn, and talk about the impacts of HIV and their community. #StopHIVTogether #EndHIVStigma
-
Listen in with Dr. Marcus Conant as he discusses #genetherapy for HIV suppression with CGTLive here https://loom.ly/zllWHkQ
Marcus Conant, MD, on Investigating Gene Therapy for HIV Suppression
cgtlive.com